Icatibant · ICATIBANT ACETATE 30 mg/3mL · Injection, Solution · Subcutaneous · Eugia US LLC
NDC 55150-0351-03 · 3 CARTON in 1 CARTON / 1 SYRINGE, GLASS in 1 CARTON / 3 mL in 1 SYRINGE, GLASS · ANDA · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Eugia US LLC | ICATIBANT ACETATE 30 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | ICATIBANT ACETATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | ICATIBANT ACETATE 30 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | ICATIBANT ACETATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Icatibant — NDC 55150-0351-03," retrieved September 3, 2026, https://drugdashboards.com/drug/55150035103.
Free to cite with attribution — see how the data is put together.